Rankings
▼
Calendar
STAA
STAAR Surgical Company
$860M
FY 2025 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$239M
-23.7% YoY
Gross Profit
$182M
76.2% margin
Operating Income
-$92M
-38.3% margin
Net Income
-$80M
-33.6% margin
EPS (Diluted)
$-1.62
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$34M
Stock-Based Comp.
$31M
Balance Sheet
Total Assets
$452M
Total Liabilities
$107M
Stockholders' Equity
$344M
Cash & Equivalents
$153M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$239M
$314M
-23.7%
Gross Profit
$182M
$240M
-23.9%
Operating Income
-$92M
-$13M
-627.2%
Net Income
-$80M
-$20M
-298.1%
← Q4 2024
All Quarters
Q1 2025 →
STAA FY 2025 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena